PU.1/Spi-B regulation of c-rel is essential for mature B cell survival

被引:41
作者
Hu, CJ
Rao, S
Ramirez-Bergeron, DL
Garrett-Sinha, LA
Gerondakis, S
Clark, MR
Simon, MC [1 ]
机构
[1] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA
[3] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA
[4] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[5] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia
关键词
D O I
10.1016/S1074-7613(01)00219-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
PU.1(+/-)Spi-B-/- mice exhibit reduced numbers of immature and mature B lymphocytes, which exhibit severe defects in response to BCR-mediated stimulation and poor survival. We found that expression of c-rel, a member of the Rel/NF-kappaB family, is dramatically reduced in PU.1(+/-)Spi-B-/- splenic B cells. Analysis of the murine c-rel promoter identified three PU.1/Spi-B binding sites critical for c-rel promoter activity. Furthermore, reintroduction of Rel protein restored wild-type B cell numbers to mice reconstituted with PU.1(+/-)Spi-B-/- bone marrow. These findings are the first to demonstrate that a member of the Rel/NF-kappaB family is directly regulated by Ets proteins and dissect the molecular basis for the function of two Ets factors, PU.1 and Spi-B, in promoting B lymphocyte survival.
引用
收藏
页码:545 / 555
页数:11
相关论文
共 56 条
[1]   HIGH-LEVELS OF C-REL EXPRESSION ARE ASSOCIATED WITH PROGRAMMED CELL-DEATH IN THE DEVELOPING AVIAN EMBRYO AND IN BONE-MARROW CELLS IN-VITRO [J].
ABBADIE, C ;
KABRUN, N ;
BOUALI, F ;
SMARDOVA, J ;
STEHELIN, D ;
VANDENBUNDER, B ;
ENRIETTO, PJ .
CELL, 1993, 75 (05) :899-912
[2]  
Anderson MK, 1999, DEVELOPMENT, V126, P3131
[3]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[4]   Spi-C, a novel Ets protein that is temporally regulated during B lymphocyte development [J].
Bemark, M ;
Mårtensson, A ;
Liberg, D ;
Leanderson, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (15) :10259-10267
[5]   The Rel/NF-κB family directly activates expression of the apoptosis inhibitor Bcl-xL [J].
Chen, CL ;
Edelstein, LC ;
Gélinas, C .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (08) :2687-2695
[6]   NEUTROPHILS AND MONOCYTES EXPRESS HIGH-LEVELS OF PU.1 (SPI-1) BUT NOT SPI-B [J].
CHEN, HM ;
ZHANG, P ;
VOSO, MT ;
HOHAUS, S ;
GONZALEZ, DA ;
GLASS, CK ;
ZHANG, DE ;
TENEN, DG .
BLOOD, 1995, 85 (10) :2918-2928
[7]   PU-1 IS A COMPONENT OF A MULTIPROTEIN COMPLEX WHICH BINDS AN ESSENTIAL SITE IN THE MURINE IMMUNOGLOBULIN LAMBDA-2-4 ENHANCER [J].
EISENBEIS, CF ;
SINGH, H ;
STORB, U .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (10) :6452-6461
[8]   Requirement for NF-κB in osteoclast and B-cell development [J].
Franzoso, G ;
Carlson, L ;
Xing, LP ;
Poljak, L ;
Shores, EW ;
Brown, KD ;
Leonardi, A ;
Tran, T ;
Boyce, BF ;
Siebenlist, U .
GENES & DEVELOPMENT, 1997, 11 (24) :3482-3496
[9]   PU.1 and Spi-B are required for normal B cell receptor-mediated signal transduction [J].
Garrett-Sinha, LA ;
Su, GH ;
Rao, S ;
Kabak, S ;
Hao, ZP ;
Clark, MR ;
Simon, MC .
IMMUNITY, 1999, 10 (04) :399-408
[10]   Genetic approaches in mice to understand Rel/NF-κB and IκB function:: transgenics and knockouts [J].
Gerondakis, S ;
Grossmann, M ;
Nakamura, Y ;
Pohl, T ;
Grumont, R .
ONCOGENE, 1999, 18 (49) :6888-6895